Surgaflex™
Acute and Surgical Wounds
CommercialActive
Key Facts
About Imbed Biosciences
Imbed Biosciences is an innovator in advanced wound care, leveraging its proprietary SAM™ platform to create ultra-thin, fully synthetic, and antimicrobial hydrogel matrices. The company has a commercial portfolio including Surgaflex™, Pelashield™, and Microlyte® brands, recently enhanced with the launch of SAM™ PainGuard™, which integrates lidocaine for dual-action pain and infection management. As a private, revenue-generating medical device manufacturer with FDA registration and ISO 13485 certification, Imbed targets a significant global wound care market with its differentiated, synthetic alternatives to biological grafts.
View full company profile